Rafael Escandon, DrPH;MPH;PhD

Bainbridge Island, Washington, United States
Rafael Escandon has been involved in clinical research and development of drugs, biologics, and gene therapies since the 1990s. He developed an interest in ethics, justice, and post-trial access while conducting clinical trials in developing and emerging countries. Rafael believes that sponsors and investigators can serve patient populations best if they plan ahead – anticipating the challenges that emerge before, during, and after trial completion. Over the past decade, Rafael has been focused on advanced therapies, such as ERTs and gene therapies for rare conditions, and is a member of the Pediatric Gene Therapy Medical Ethics working group. His hope is that practical approaches can be identified for the myriad challenging ethical considerations as these therapies advance through clinical trials and emerge into the commercial marketplace.
Speaking In
2:15 PM - 3:15 PM (PDT)
Monday, June 13
Individualized antisense oligonucleotide (ASO) technology is increasingly capturing the attention…